Terns Pharmaceuticals Selected for Oral Presentation at European Hematology Association Congress for Preclinical Data on Novel Allosteric BCR-Abl Inhibitor Tern-701
admin | July 26, 2023
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor…
READ MORE